SGA
UTHR icon

Sector Gamma AS’s United Therapeutics UTHR Stock Holding History

Sector Gamma AS’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-162,554
Closed -$15.4M – 34
2020
Q1 		$15.4M Buy
162,554
+11,939
+8% +$1.13M 3.29% 12
2019
Q4 		$13.3M Buy
150,615
+2,468
+2% +$217K 2.12% 19
2019
Q3 		$11.8M Buy
+148,147
New +$11.9M 2% 19
2017
Q2 		– Sell
-28,974
Closed -$3.92M – 27
2017
Q1 		$3.92M Sell
28,974
-39,000
-57% -$5.91M 0.62% 26
2016
Q4 		$9.75M Sell
67,974
-15,500
-19% -$1.98M 1.83% 20
2016
Q3 		$9.98M Buy
83,474
+2,250
+3% +$270K 1.75% 22
2016
Q2 		$8.6M Buy
81,224
+21,020
+35% +$2.34M 1.63% 22
2016
Q1 		$6.71M Buy
+60,204
New +$7.62M 1.38% 23
2014
Q2 		– Sell
-62,510
Closed -$5.88M – 33
2014
Q1 		$5.88M Buy
62,510
+23,600
+61% +$2.41M 1.41% 26
2013
Q4 		$4.4M Buy
38,910
+2,400
+7% +$216K 1.19% 26
2013
Q3 		$2.88M Buy
36,510
+4,200
+13% +$307K 0.74% 31
2013
Q2 		$2.13M Buy
+32,310
New +$2.08M 0.62% 30

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sector Gamma AS's UTHR Position: Q2 2020 in Review

Sector Gamma AS sold out of United Therapeutics (UTHR) in Q2 2020, closing a stake of 162,554 shares — an estimated $15.4M sold.

Sector Gamma AS first reported a position in UTHR in Q2 2013 and held it in 12 quarters. The position peaked at $15.4M in Q1 2020. 349 funds tracked by Wall St. Rank hold UTHR as of Q2 2020.

  • Sector Gamma AS reported no remaining United Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Sector Gamma AS sold 162,554 United Therapeutics shares in Q2 2020, an estimated $15.4M.
  • Sector Gamma AS first reported a position in United Therapeutics in Q2 2013 and held it in 12 quarters.
  • Sector Gamma AS's United Therapeutics position peaked at $15.4M in Q1 2020.
  • 349 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2020.

Based on Sector Gamma AS's 13F filing for Q2 2020, filed 7 Aug 2020.